Search results
BenevolentAI and AstraZeneca discover novel heart failure target using AI
Proactive Investors· 30 minutes agoBenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its...
Noxopharm scales up production of lupus drug SOF-SKN™ to GLP standards
Proactive Investors· 1 day agoNoxopharm Ltd (ASX:NOX, OTC:NOXOF) has reached a major drug development milestone in scaling up...
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress By Investing.com
Investing.com· 14 hours agoInnate Pharma SA (OTC:IPHYF) (IPHA) discussed its first quarter 2024 financial results and provided...
FDA fast track status granted to iECURE neonatal OTC deficiency treatment
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe therapeutic benefits of ECUR-506 have been recognised previously, with the FDA awarding it rare...
Race Oncology higher as bisantrene is combined with decitabine to enhance killing of multiple cancer...
Proactive Investors· 21 hours agoRace Oncology Ltd (ASX:RAC, OTC:RAONF) is trading higher on findings that combining bisantrene with...
Earnings call: CV Sciences posts a revenue of $4 million By Investing.com
Investing.com· 11 hours agoCV Sciences (OTC:CVSI), a leader in the natural product retail channel, has reported a revenue of $4...
Lialda interactions: Other medications, alcohol, and more
Medical News Today· 21 hours agoLialda (mesalamine) is a brand-name oral tablet prescribed for ulcerative colitis. Lialda has...
FDA: Cue Health COVID tests may return false positive, negative results, so throw them away
Naples Daily News via Yahoo News· 20 hours ago"Consider retesting using a different COVID-19 test that received FDA authorization if you tested...
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
Reuters via AOL· 6 days agoViatris, formed by the merger of Mylan and Pfizer's Upjohn business, makes generic and key branded drugs such as erectile dysfunction drug Viagra, anti-anxiety medication ...
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...
WJTV Jackson· 12 hours agoNanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive ...